VEGFA and cancer: However, other NPY receptors have been implicated in promoting tumorigenicity in other cancers; for example, NPY2R is up-regulated in vascular endothelial growth factor A–depleted orthotopic models of colon cancer, and NPY2R antagonists inhibited angiogenesis and tumor growth in these models (55).